Genovis AB: Half-Yearly Report January-June 2023
-
Genovis AB: Half-Yearly Report January-June 2023
https://mb.cision.com/Main/1712/3820614/2247306.pdf
Half-Yearly Report January-June 2023
Continued strong growth in both enzyme and antibody business April – June 2023 · Net sales
News Powered by Cision (news.cision.com)
Continued strong growth in both enzyme and antibody business
January - June 2023
Net sales totaled SEK 100,739 (53,667) thousand, with a growth rate of 88%. Growth is 76%, adjusted for currency effects. Organic growth adjusted for license revenues in the first quarter from Selecta Biosciences is 41%, and 30% when also adjusted for currency effects .....
Rigtigt godt regnskab fra Genovis.
Luk i kurs 49,15 & +13,12%
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind